Last Updated: 04/06/07
CTEP Scientific Advances
- Trastuzumab Combined with Chemotherapy Improves Disease-Free Survival for Patients with Early-Stage Breast Cancer
- Oncotype DX® Test Predicts Breast Cancer Recurrence Risk and Chemotherapy Benefit
- Benefit of Antiangiogenic Therapy in Patients with Breast Cancer
- Paclitaxel after Doxorubicin Plus Cyclophosphamide as Adjuvant Chemotherapy for Node-Positive Breast Cancer Increases Disease-Free Survival
- Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer Improves DFS
- Paclitaxel-Carboplatin-Bevacizumab Represents New Treatment Standard for Metastatic Non- Squamous Non-Small Cell Lung Cancer
- Adding Bevacizumab to Oxaliplatin-Based Chemotherapy Prolongs Survival for Previously Treated Patients with Advanced Colorectal Cancer
- Oxaliplatin in Combination with a Bolus 5-Fluorouracil/Leucovorin Regimen Reduces Recurrence in Early Stage Colon Cancer
- Laparoscopic Colectomy Is an Acceptable Alternative to Open Colectomy for Colon Cancer
- Oxaliplatin-Based Regimen Permits Successful Resection of Metastatic Colorectal Cancer
- Continuous-Infusion Fluorouracil Diminishes Severe Toxicity but Does Not Improve DFS or OS in Adjuvant Treatment of Stage III and High-Risk Stage II Colon Cancer
- Sentinel Nodes Predict Survival for Melanoma Patients
- Cisplatin Plus Topotecan Gives Patients with Advanced Cervical Cancer More Time
- Nelarabine Active in T-Cell Leukemia and Lymphoma
- Adoptive Immunotherapy Makes Mismatched Hematopoietic Stem Cell Transplantation Possible
